Ganguly R, Clem L W, Bencić Z, Sinha R, Sakazaki R, Waldman R H
Bull World Health Organ. 1975;52(3):323-30.
The efficacy of various cholera vaccines in eliciting an intestinal antibody response was assessed in human volunteers who received oral live, oral killed, or parenteral cholera vaccines, or placebo. The intestinal immune response in terms of antibacterial and antitoxin antibodies was determined 2 and 4 weeks after immunization. By means of the mouse peritoneum opsonization assay and the infant mouse protection test, antibacterial activity could be detected in the intestinal secretions of volunteers who had been immunized either orally or by the parenteral route. Significant protective activity and duration of immunity were observed with the oral killed vaccine. The bacteriological data indicated the absence of significant intestinal colonization of the live attenuated strain after oral administration, and probably explains the observed lack of effectiveness of the oral vaccine compared with that of the killed vaccine. The predominant immunoglobulin class of intestinal antibody was found to be IgA. None of the vaccines used in the study elicited significant antitoxin activity in the intestinal secretions, as determined by the skin permeability neutralization test.
在接受口服活疫苗、口服灭活疫苗、注射用霍乱疫苗或安慰剂的人类志愿者中,评估了各种霍乱疫苗引发肠道抗体反应的效力。在免疫后2周和4周测定了肠道针对抗菌和抗毒素抗体的免疫反应。通过小鼠腹膜调理吞噬试验和幼鼠保护试验,在经口服或注射途径免疫的志愿者的肠道分泌物中可检测到抗菌活性。口服灭活疫苗具有显著的保护活性和免疫持续时间。细菌学数据表明口服后减毒活菌株在肠道内无明显定植,这可能解释了观察到的口服疫苗与灭活疫苗相比缺乏有效性的原因。肠道抗体的主要免疫球蛋白类别为IgA。根据皮肤通透性中和试验,研究中使用的任何疫苗均未在肠道分泌物中引发显著的抗毒素活性。